Reagents

The complete TECO Medical reagent portfolio — clotting tests, chromogenic and immunological assays, controls, calibrators, and factor deficient plasmas.
For professional use only

Clotting tests

5
A0230

TEClot PT-S

Clotting test for the quantitative determination of prothrombin time (PT) in citrated human plasma according to Quick. Sensitive to all intrinsic factors II, V, VII, X and fibrinogen.

Lyophilized reagent, High sensitivity (ISI~1,0), Excellent stability.

5x2ml (200det)10x4ml (800det)10x10ml (2000det)
A0260

TEClot PT-B

Clotting test for the quantitative determination of prothrombin time (PT) in citrated human plasma or whole blood according to Owren. Sensitive only to factor II, VII,X.

Lyophilized reagent, Traceable to WHO IRP67/40, through RBT90, Not influenced by patients with Factor V or Fibrinogen levels, Insensitive to LA, Excellent precision between INR 1-6. Kit contains: 5x10ml PT-B , 5x5ml Diluent, 5x5ml CaCl2

Kit (333det)
A0320

TEClot APTT-S

Clotting test for quantitative determination of the Activated Partial Thromboplastin Time (APTT) in citrated human plasma using silicate as contact activator for factor XII.

Ready to use (liquid), Near colloidal silicat contact activator, Insensitive for LA, Highly sensitive UFH, Excellent factor sensitivity

10x5ml (2000det)
A0401

TEClot TT

Clotting test for quantitative determination of the Thrombin Time (TT) in citrated human plasma.

Lyophilized reagent, High sensitivity to UFH and Dabigatran, Excellent stability.

10x2ml (800det)
A0511

TEClot FIB

intended for the quantitative determination of Fibrinogen concentration in human citrated plasma according to Clauss.

Lyophilized reagent, Excellent stability, ~ 100 UNIH/ml, Linearity up to 800 mg/dL (8 g/L)

10x2ml (800det)10x5ml (2000det)

Chromogenic tests

1

Immunologic tests

2

Calibrator and Control Plasma

5

Deficient Plasma

8
P5001

Deficient Plasma Factor II

Screening of bleeding disorders caused by factor II deficiency. This product is intended for the quantitative determination of factor II in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5101

Deficient Plasma Factor V

Screening of bleeding disorders caused by factor V deficiency. This product is intended for the quantitative determination of factor V in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5201

Deficient Plasma Factor VII

Screening of bleeding disorders caused by factor VII deficiency. This product is intended for the quantitative determination of factor VII in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5301

Deficient Plasma Factor VIII

Screening of bleeding disorders caused by factor VIII deficiency. This product is intended for the quantitative determination of factor VIII in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5401

Deficient Plasma Factor IX

Screening of bleeding disorders caused by factor IX deficiency. This product is intended for the quantitative determination of factor IX in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5501

Deficient Plasma Factor X

Screening of bleeding disorders caused by factor X deficiency. This product is intended for the quantitative determination of factor X in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5601

Deficient Plasma Factor XI

Screening of bleeding disorders caused by factor XI deficiency. This product is intended for the quantitative determination of factor XI in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)
P5701

Deficient Plasma Factor XII

Screening of bleeding disorders caused by factor XII deficiency. This product is intended for the quantitative determination of factor XII in human plasma by clotting assay.

Immunodepleted, Lyophilized (dried)

10x1ml (400det)

Auxilary reagents

3

Certified Quality

Ongoing certifications and quality assurance are self-evident. Manufacturing facilities operate under strict DIN EN ISO 13485 guidelines, ensuring highest medical device standards.

Continuous Research

Innovation and further development is our corporate identity. Dedicated R&D teams constantly innovating to bring advanced diagnostic capabilities to modern clinical environments.

Global Experience

Decades of expertise in hemostasis with a robust international distribution network, providing reliable support.